Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies and ω-3 Not Working in Clinical Trials?

Fiala M, Restrepo L, Pellegrini M.

J Alzheimers Dis. 2018;62(3):1013-1022. doi: 10.3233/JAD-170579. Review.

2.

Omega-3 fatty acids increase the unfolded protein response and improve amyloid-β phagocytosis by macrophages of patients with mild cognitive impairment.

Olivera-Perez HM, Lam L, Dang J, Jiang W, Rodriguez F, Rigali E, Weitzman S, Porter V, Rubbi L, Morselli M, Pellegrini M, Fiala M.

FASEB J. 2017 Oct;31(10):4359-4369. doi: 10.1096/fj.201700290R. Epub 2017 Jun 20. Erratum in: FASEB J. 2017 Dec;31(12 ):5625.

3.

Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.

Fiala M, Kooij G, Wagner K, Hammock B, Pellegrini M.

FASEB J. 2017 Aug;31(8):3229-3239. doi: 10.1096/fj.201700065R. Epub 2017 Apr 18. Review.

4.

Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation.

Famenini S, Rigali EA, Olivera-Perez HM, Dang J, Chang MT, Halder R, Rao RV, Pellegrini M, Porter V, Bredesen D, Fiala M.

FASEB J. 2017 Jan;31(1):148-160. doi: 10.1096/fj.201600677RR. Epub 2016 Sep 27.

5.

Epigenetic changes in T-cell and monocyte signatures and production of neurotoxic cytokines in ALS patients.

Lam L, Chin L, Halder RC, Sagong B, Famenini S, Sayre J, Montoya D, Rubbi L, Pellegrini M, Fiala M.

FASEB J. 2016 Oct;30(10):3461-3473. Epub 2016 Jul 1.

6.

Reversal of cognitive decline in Alzheimer's disease.

Bredesen DE, Amos EC, Canick J, Ackerley M, Raji C, Fiala M, Ahdidan J.

Aging (Albany NY). 2016 Jun;8(6):1250-8. doi: 10.18632/aging.100981.

7.

Anti-inflammatory therapies of amyotrophic lateral sclerosis guided by immune pathways.

Lam L, Halder RC, Montoya DJ, Rubbi L, Rinaldi A, Sagong B, Weitzman S, Rubattino R, Singh RR, Pellegrini M, Fiala M.

Am J Neurodegener Dis. 2015 Dec 28;4(2):28-39. eCollection 2015.

8.

Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment.

Fiala M, Terrando N, Dalli J.

J Alzheimers Dis. 2016;49(4):1191. doi: 10.3233/JAD-159008. No abstract available.

PMID:
26756328
9.
10.

Development of effective therapy for sporadic ALS.

Fiala M, Pellegrini M.

Expert Opin Biol Ther. 2015;15(8):1249. doi: 10.1517/14712598.2015.1055673. No abstract available.

PMID:
26160493
11.

Curcuminoids and ω-3 fatty acids with anti-oxidants potentiate cytotoxicity of natural killer cells against pancreatic ductal adenocarcinoma cells and inhibit interferon γ production.

Halder RC, Almasi A, Sagong B, Leung J, Jewett A, Fiala M.

Front Physiol. 2015 May 22;6:129. doi: 10.3389/fphys.2015.00129. eCollection 2015.

12.

ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment.

Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE.

FASEB J. 2015 Jul;29(7):2681-9. doi: 10.1096/fj.14-264218. Epub 2015 Mar 24.

PMID:
25805829
14.

Tocilizumab infusion therapy normalizes inflammation in sporadic ALS patients.

Fiala M, Mizwicki MT, Weitzman R, Magpantay L, Nishimoto N.

Am J Neurodegener Dis. 2013 Jun 21;2(2):129-39. Print 2013.

15.

Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling.

Mizwicki MT, Fiala M, Magpantay L, Aziz N, Sayre J, Liu G, Siani A, Chan D, Martinez-Maza O, Chattopadhyay M, La Cava A.

Am J Neurodegener Dis. 2012;1(3):305-15. Epub 2012 Nov 21.

16.

1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients.

Mizwicki MT, Liu G, Fiala M, Magpantay L, Sayre J, Siani A, Mahanian M, Weitzman R, Hayden EY, Rosenthal MJ, Nemere I, Ringman J, Teplow DB.

J Alzheimers Dis. 2013;34(1):155-70. doi: 10.3233/JAD-121735.

17.

Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: inhibition of inflammation by resolvin D1.

Liu G, Fiala M, Mizwicki MT, Sayre J, Magpantay L, Siani A, Mahanian M, Chattopadhyay M, La Cava A, Wiedau-Pazos M.

Am J Neurodegener Dis. 2012;1(1):60-74.

18.

Chemotactic and mitogenic stimuli of neuronal apoptosis in patients with medically intractable temporal lobe epilepsy.

Fiala M, Avagyan H, Merino JJ, Bernas M, Valdivia J, Espinosa-Jeffrey A, Witte M, Weinand M.

Pathophysiology. 2013 Feb;20(1):59-69. doi: 10.1016/j.pathophys.2012.02.003. Epub 2012 Mar 22.

19.

Genomic and nongenomic signaling induced by 1α,25(OH)2-vitamin D3 promotes the recovery of amyloid-β phagocytosis by Alzheimer's disease macrophages.

Mizwicki MT, Menegaz D, Zhang J, Barrientos-Durán A, Tse S, Cashman JR, Griffin PR, Fiala M.

J Alzheimers Dis. 2012;29(1):51-62. doi: 10.3233/JAD-2012-110560.

PMID:
22207005
20.

Delineating Alzheimer's disease progression with MGAT3, a biomarker for improved prognosis and personalized therapy.

Fiala M, Porter V.

Biomark Med. 2011 Oct;5(5):645-7. doi: 10.2217/bmm.11.64. No abstract available.

Supplemental Content

Loading ...
Support Center